Código QR (código de barras bidimensional)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease

Interstitial lung disease (ILD) represents a severe pulmonary complication of connective tissue diseases, rheumatoid arthritis (RA), and antineutrophil cytoplasmic antibodyassociated vasculitis. Treatment of ILD, mainly based on immunosuppression, remains challenging. Rituximab (RTX), a monoclonal a...

ver descrição completa

Na minha lista:
Principais autores: Caterina Vacchi, Andreina Manfredi, Giulia Cassone, Gian Luca Erre, Carlo Salvarani, Marco Sebastiani
Formato: Artigo
Idioma:Inglês
Publicado em: BioExcel Publishing Ltd 2021-01-01
coleção:Drugs in Context
Assuntos:
connective tissue diseases
efficacy
interstitial lung disease
lung fibrosis
rheumatic diseases
rituximab
safety
Acesso em linha:https://www.drugsincontext.com/efficacy-and-safety-of-rituximab-in-the-treatment-of-connective-tissue-disease-related-interstitial-lung-disease
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados